ESR1 and breast carcinoma: In our laboratory, we reported the absolute concentration of tCho in patients with early breast cancer (n = 31), LABC (n = 120), normal breast of healthy volunteers (n = 31), and benign breast lesions (n = 38), and also an association of tCho concentration with ER, PR, and HER2neu status.